Please use this identifier to cite or link to this item:
http://hdl.handle.net/1893/21273
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zimmerman, Yvette | en_UK |
dc.contributor.author | Foidart, Jean-Michel | en_UK |
dc.contributor.author | Pintiaux, Axelle | en_UK |
dc.contributor.author | Minon, Jean-Marc | en_UK |
dc.contributor.author | Fauser, Bart C J M | en_UK |
dc.contributor.author | Cobey, Kelly D | en_UK |
dc.contributor.author | Coelingh Bennink, Herjan J T | en_UK |
dc.date.accessioned | 2016-05-17T01:46:32Z | - |
dc.date.available | 2016-05-17T01:46:32Z | - |
dc.date.issued | 2015-02 | en_UK |
dc.identifier.uri | http://hdl.handle.net/1893/21273 | - |
dc.description.abstract | Objectives: Combined oral contraceptives (COCs) decrease testosterone (T) levels. This study investigated restoration of T and other androgen concentrations during COC use by co-administration of dehydroepiandrosterone (DHEA). Study design: In this randomized, double-blind, placebo-controlled study in 99 new COC starters (18-35 years old with BMI range 18-34 kg/m2), a COC containing 30 μg ethinylestradiol (EE) and 3 mg drospirenone (DRSP) was used for 3 cycles, followed by 6 cycles of the same COC combined with either 50 mg/day DHEA or placebo. Total T, albumin, sex hormone-binding globulin (SHBG), DHEA-sulfate (DHEA-S), Δ4-androstenedione (AD), 3α-androstanediol glucuronide (ADG) and estradiol (E2) were measured, whereas free T and the free T index (FTI) were calculated. Assessments took place at baseline (no COC use), after the run-in period (COC use alone) and during the treatment period (DHEA or placebo). Results: During COC use alone androgen levels decreased, especially total T by 62% and free T by 86%, and SHBG increased by 243%. Total T increased with DHEA compared to placebo (change from end of run-in period to end of treatment period: 1.3 ± 1.2 nmol/L vs 0.0 ± 0.4 nmol/L; P < 0.0001), and was restored to baseline levels. Free T and the FTI increased significantly (P < 0.0001), but the free T level was still 53% below baseline levels. DHEA-S, AD and ADG increased significantly to levels above baseline (P < 0.0001 for each). DHEA had no effect on SHBG, albumin and E2. Conclusions: An EE/DRSP containing COC strongly suppressed endogenous androgen concentrations in all users. The addition of 50 mg DHEA to a COC regimen containing EE/DRSP restored total T to baseline levels, but free T levels were restored by only 47% as most of the T remains bound to SHBG. Implications: When using a COC that increases SHBG considerably, a daily dose of 50 mg DHEA is insufficient to normalize free T levels completely. | en_UK |
dc.language.iso | en | en_UK |
dc.publisher | Elsevier | en_UK |
dc.relation | Zimmerman Y, Foidart J, Pintiaux A, Minon J, Fauser BCJM, Cobey KD & Coelingh Bennink HJT (2015) Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I Endocrine effects. Contraception, 91 (2), pp. 127-133. https://doi.org/10.1016/j.contraception.2014.11.002 | en_UK |
dc.rights | Published in Contraception by Elsevier; Elsevier believes that individual authors should be able to distribute their AAMs for their personal voluntary needs and interests, e.g. posting to their websites or their institution’s repository, e-mailing to colleagues. However, our policies differ regarding the systematic aggregation or distribution of AAMs to ensure the sustainability of the journals to which AAMs are submitted. Therefore, deposit in, or posting to, subject-oriented or centralized repositories (such as PubMed Central), or institutional repositories with systematic posting mandates is permitted only under specific agreements between Elsevier and the repository, agency or institution, and only consistent with the publisher’s policies concerning such repositories. Voluntary posting of AAMs in the arXiv subject repository is permitted. | en_UK |
dc.subject | free testosterone | en_UK |
dc.subject | SHBG | en_UK |
dc.subject | DHEA | en_UK |
dc.subject | androgens | en_UK |
dc.title | Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I Endocrine effects | en_UK |
dc.type | Journal Article | en_UK |
dc.identifier.doi | 10.1016/j.contraception.2014.11.002 | en_UK |
dc.citation.jtitle | Contraception | en_UK |
dc.citation.issn | 0010-7824 | en_UK |
dc.citation.volume | 91 | en_UK |
dc.citation.issue | 2 | en_UK |
dc.citation.spage | 127 | en_UK |
dc.citation.epage | 133 | en_UK |
dc.citation.publicationstatus | Published | en_UK |
dc.citation.peerreviewed | Refereed | en_UK |
dc.type.status | AM - Accepted Manuscript | en_UK |
dc.author.email | kelly.cobey@stir.ac.uk | en_UK |
dc.citation.date | 13/11/2014 | en_UK |
dc.contributor.affiliation | Pantarhei Bioscience BV, The Netherlands | en_UK |
dc.contributor.affiliation | University Hospital CHR Citadelle | en_UK |
dc.contributor.affiliation | University Hospital CHR Citadelle | en_UK |
dc.contributor.affiliation | University Hospital CHR Citadelle | en_UK |
dc.contributor.affiliation | Utrecht University | en_UK |
dc.contributor.affiliation | Psychology | en_UK |
dc.contributor.affiliation | Pantarhei Bioscience BV, The Netherlands | en_UK |
dc.identifier.isi | WOS:000348896300007 | en_UK |
dc.identifier.scopusid | 2-s2.0-84921051393 | en_UK |
dc.identifier.wtid | 611361 | en_UK |
dc.contributor.orcid | 0000-0003-2797-1686 | en_UK |
dc.date.accepted | 2014-11-02 | en_UK |
dcterms.dateAccepted | 2014-11-02 | en_UK |
dc.date.filedepositdate | 2014-11-25 | en_UK |
rioxxterms.apc | not required | en_UK |
rioxxterms.type | Journal Article/Review | en_UK |
rioxxterms.version | AM | en_UK |
local.rioxx.author | Zimmerman, Yvette| | en_UK |
local.rioxx.author | Foidart, Jean-Michel| | en_UK |
local.rioxx.author | Pintiaux, Axelle| | en_UK |
local.rioxx.author | Minon, Jean-Marc| | en_UK |
local.rioxx.author | Fauser, Bart C J M| | en_UK |
local.rioxx.author | Cobey, Kelly D|0000-0003-2797-1686 | en_UK |
local.rioxx.author | Coelingh Bennink, Herjan J T| | en_UK |
local.rioxx.project | Internal Project|University of Stirling|https://isni.org/isni/0000000122484331 | en_UK |
local.rioxx.freetoreaddate | 2014-11-25 | en_UK |
local.rioxx.licence | http://www.rioxx.net/licenses/all-rights-reserved|2014-11-25| | en_UK |
local.rioxx.filename | endocrine.pdf | en_UK |
local.rioxx.filecount | 1 | en_UK |
local.rioxx.source | 0010-7824 | en_UK |
Appears in Collections: | Psychology Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
endocrine.pdf | Fulltext - Accepted Version | 548.92 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.